José Guillermo Cabanillas López and Juan De Dios Yépez Florian. Polyserositis as a Probable Early Manifestation of Systemic Lupus Erythematosus.
. 2022; 10(7):173-177. doi: 10.12691/AJMCR-10-7-3
systemic lupus erythematosus, pericardial effusion, pleural effusion, antinuclear antibodies
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit
[1] | Aringer, M., Costenbader, K., Daikh, D., Brinks, R., Mosca, M., Ramsey-Goldman, R., Smolen, J. S., Wofsy, D., Boumpas, D. T., Kamen, D. L., Jayne, D., Cervera, R., Costedoat-Chalumeau, N., Diamond, B., Gladman, D. D., Hahn, B., Hiepe, F., Jacobsen, S., Khanna, D., … Johnson, S. R. (2019). 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis & Rheumatology, 71(9), 1400-1412. |
|
[2] | Fava A, Petri M. Systemic lupus erythematosus: Diagnosis and clinical management. J Autoimmun. 2019 Jan; 96: 1-13. |
|
[3] | Fanouriakis A, Bertsias G. Changing paradigms in the treatment of systemic lupus erythematosus. Lupus Sci Med. 2019 Feb 8; 6(1): e000310. |
|
[4] | González Jiménez, D., Mejía Bonilla, S., & Cruz Fallas, M. (2021). Lupus eritematoso sistémico: enfoque general de la enfermedad. Revista Medica Sinergia, 6(1), e630. |
|
[5] | Bertsias, G., Fanouriakis, A., & Boumpas, D. T. (2017). Treatment of systemic lupus erythematosus. In G. S. Firestein, R. C. Budd, S. E. Gabriel, I. B. McInnes, & J. R. O’Dell (Eds.), Kelley and Firestein’s Textbook of Rheumatology (pp. 1368-1388.e5). Elsevier. |
|
[6] | Systemic lupus erythematosus (SLE) clinical presentation. (2022, June 21). Medscape.com. https://emedicine.medscape.com/article/332244-clinical. |
|
[7] | Ferretti, C., & La Cava, A. (2016). Overview of the pathogenesis of systemic lupus erythematosus. In G. C. Tsokos (Ed.), Systemic Lupus Erythematosus (pp. 55-62). Elsevier. |
|
[8] | Rind, A., & Isenberg, D. A. (2022). Systemic Lupus Erythematosus. In T. Kenakin (Ed.), Comprehensive Pharmacology (pp. 447-460). Elsevier. |
|
[9] | Losada I, González-Moreno J, Roda N, Ventayol L, Borjas Y, Domínguez FJ, Fernández-Baca V, García-Gasalla M, Payeras A. Polyserositis: a diagnostic challenge. Intern Med J. 2018 Aug; 48(8): 982-987. |
|
[10] | Granja Romero, E., Trinidad Sanjosé, J. C., González Rivero, C., & Del Río Romero, D. (2010). Serositis pleuroperitoneal como manifestación de un lupus inducido por pirazolonas (metamizol). Reumatologia clinica, 6(2), 117-118. |
|
[11] | Zampeli, E., Skopouli, F. N., & Moutsopoulos, H. M. (2018). Polyserositis in a patient with active systemic lupus erythematosus: A case of pseudo-pseudo Meigs syndrome. The Journal of Rheumatology, 45(6), 877-878. |
|